{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:37:30Z","timestamp":1792514250070,"version":"4.5.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02067-4","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T02:22:06Z","timestamp":1743214926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives"],"prefix":"10.1007","volume":"16","author":[{"given":"Zixun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.567650","volume":"12","author":"X Yang","year":"2021","unstructured":"Yang X, et al. Pathophysiologic role of neurotransmitters in digestive diseases. Front Physiol. 2021;12: 567650. https:\/\/doi.org\/10.3389\/fphys.2021.567650.","journal-title":"Front Physiol"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","volume":"31","author":"B Boilly","year":"2017","unstructured":"Boilly B, Faulkner S, Jobling P, Hondermarck H. Nerve dependence: from regeneration to cancer. Cancer Cell. 2017;31:342\u201354. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.005.","journal-title":"Cancer Cell"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/cncr.20198","volume":"100","author":"SI Hajdu","year":"2004","unstructured":"Hajdu SI. Greco-Roman thought about cancer. Cancer. 2004;100:2048\u201351. https:\/\/doi.org\/10.1002\/cncr.20198.","journal-title":"Cancer"},{"key":"2067_CR4","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/ijc.29134","volume":"136","author":"GB Faguet","year":"2015","unstructured":"Faguet GB. A brief history of cancer: age-old milestones underlying our current knowledge database. Int J Cancer. 2015;136:2022\u201336. https:\/\/doi.org\/10.1002\/ijc.29134.","journal-title":"Int J Cancer"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"MJ Bissell","year":"2011","unstructured":"Bissell MJ, Hines WC. Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011;17:320\u20139. https:\/\/doi.org\/10.1038\/nm.2328.","journal-title":"Nat Med"},{"key":"2067_CR6","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1989;8:98\u2013101.","journal-title":"Cancer Metastasis Rev"},{"key":"2067_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/nejm197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182\u20136. https:\/\/doi.org\/10.1056\/nejm197111182852108.","journal-title":"N Engl J Med"},{"key":"2067_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci147276","author":"SM Gysler","year":"2021","unstructured":"Gysler SM, Drapkin R. Tumor innervation: peripheral nerves take control of the tumor microenvironment. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci147276.","journal-title":"J Clin Invest"},{"key":"2067_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1158\/0008-5472.Can-20-2793","volume":"81","author":"DA Silverman","year":"2021","unstructured":"Silverman DA, et al. Cancer-associated neurogenesis and nerve-cancer cross-talk. Can Res. 2021;81:1431\u201340. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-2793.","journal-title":"Can Res"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","volume":"20","author":"AH Zahalka","year":"2020","unstructured":"Zahalka AH, Frenette PS. Nerves in cancer. Nat Rev Cancer. 2020;20:143\u201357. https:\/\/doi.org\/10.1038\/s41568-019-0237-2.","journal-title":"Nat Rev Cancer"},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-030-73119-9_15","volume":"1329","author":"C Magnon","year":"2021","unstructured":"Magnon C. The adrenergic nerve network in cancer. Adv Exp Med Biol. 2021;1329:271\u201394. https:\/\/doi.org\/10.1007\/978-3-030-73119-9_15.","journal-title":"Adv Exp Med Biol"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/cpt.2080","volume":"109","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, et al. Evolving landscape of new drug approval in japan and lags from international birth dates: retrospective regulatory analysis. Clin Pharmacol Ther. 2021;109:1265\u201373. https:\/\/doi.org\/10.1002\/cpt.2080.","journal-title":"Clin Pharmacol Ther"},{"key":"2067_CR13","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Fungal polysaccharopeptides reduce obesity by richness of specific microbiota and modulation of lipid metabolism. 375584 (2018).","DOI":"10.1101\/375584"},{"key":"2067_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.22159\/ijap.2021v13i3.40865","volume":"13","author":"SK Joseph","year":"2021","unstructured":"Joseph SK. State-of-the-art nanotechnology-based drug delivery strategies to combat covid-19. Int J App Pharm. 2021;13:18\u201329.","journal-title":"Int J App Pharm"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"2302413","DOI":"10.1080\/15384047.2024.2302413","volume":"25","author":"G Jiang","year":"2024","unstructured":"Jiang G, et al. The antipsychotic drug pimozide promotes apoptosis through the RAF\/ERK pathway and enhances autophagy in breast cancer cells. Cancer Biol Ther. 2024;25:2302413. https:\/\/doi.org\/10.1080\/15384047.2024.2302413.","journal-title":"Cancer Biol Ther"},{"key":"2067_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.14573\/altex.2011181","volume":"38","author":"K Briggs","year":"2021","unstructured":"Briggs K, et al. Guidelines for FAIR sharing of preclinical safety and off-target pharmacology data. Altex. 2021;38:187\u201397. https:\/\/doi.org\/10.14573\/altex.2011181.","journal-title":"Altex"},{"key":"2067_CR17","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2020.10.016","volume":"183","author":"RS Banh","year":"2020","unstructured":"Banh RS, et al. Neurons release serine to support mRNA translation in pancreatic cancer. Cell. 2020;183:1202-1218.e1225. https:\/\/doi.org\/10.1016\/j.cell.2020.10.016.","journal-title":"Cell"},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","volume":"33","author":"BW Renz","year":"2018","unstructured":"Renz BW, et al. \u03b22 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer. Cancer Cell. 2018;33:75-90.e77. https:\/\/doi.org\/10.1016\/j.ccell.2017.11.007.","journal-title":"Cancer Cell"},{"key":"2067_CR19","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/0008-5472.Can-13-2050","volume":"74","author":"RE Stopczynski","year":"2014","unstructured":"Stopczynski RE, et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Can Res. 2014;74:1718\u201327. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-2050.","journal-title":"Can Res"},{"key":"2067_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","volume":"20","author":"C Yao","year":"2023","unstructured":"Yao C, et al. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies. Cancer Biol Med. 2023;20:25\u201343. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0449.","journal-title":"Cancer Biol Med"},{"key":"2067_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/157339412800675333","volume":"8","author":"J Tilan","year":"2012","unstructured":"Tilan J, Czarnecka M, Kitlinska JJCCTR. Sympathetic signaling in angiogenesis: implications for cancer progression. Current Cancer Therapy Rev. 2012;8:83\u20139.","journal-title":"Current Cancer Therapy Rev"},{"key":"2067_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana RD, Albores-Garc\u00eda D, Cervantes-Villagrana AR, Garc\u00eda-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 2020;5:99. https:\/\/doi.org\/10.1038\/s41392-020-0205-z.","journal-title":"Signal Transduct Target Ther"},{"key":"2067_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025215","volume":"6","author":"S Shome","year":"2011","unstructured":"Shome S, et al. Dopamine regulates angiogenesis in normal dermal wound tissues. PLoS ONE. 2011;6: e25215. https:\/\/doi.org\/10.1371\/journal.pone.0025215.","journal-title":"PLoS ONE"},{"key":"2067_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/jci160152","author":"M Nie","year":"2022","unstructured":"Nie M, et al. Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/jci160152.","journal-title":"J Clin Invest"},{"key":"2067_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7030058","author":"M Konishi","year":"2019","unstructured":"Konishi M, Hayakawa Y, Koike K. Role of muscarinic acetylcholine signaling in gastrointestinal cancers. Biomedicines. 2019. https:\/\/doi.org\/10.3390\/biomedicines7030058.","journal-title":"Biomedicines"},{"key":"2067_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","volume":"31","author":"Y Hayakawa","year":"2017","unstructured":"Hayakawa Y, et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell. 2017;31:21\u201334. https:\/\/doi.org\/10.1016\/j.ccell.2016.11.005.","journal-title":"Cancer Cell"},{"key":"2067_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/s1470-2045(04)01597-9","volume":"5","author":"EM Reiche","year":"2004","unstructured":"Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617\u201325. https:\/\/doi.org\/10.1016\/s1470-2045(04)01597-9.","journal-title":"Lancet Oncol"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10555-023-10095-1","volume":"42","author":"Q Cui","year":"2023","unstructured":"Cui Q, Jiang D, Zhang Y, Chen C. The tumor-nerve circuit in breast cancer. Cancer Metastasis Rev. 2023;42:543\u201374. https:\/\/doi.org\/10.1007\/s10555-023-10095-1.","journal-title":"Cancer Metastasis Rev"},{"key":"2067_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","volume":"567","author":"MMS Obradovi\u0107","year":"2019","unstructured":"Obradovi\u0107 MMS, et al. Glucocorticoids promote breast cancer metastasis. Nature. 2019;567:540\u20134. https:\/\/doi.org\/10.1038\/s41586-019-1019-4.","journal-title":"Nature"},{"key":"2067_CR30","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/jnci\/dji401","volume":"97","author":"AN Saul","year":"2005","unstructured":"Saul AN, et al. Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst. 2005;97:1760\u20137. https:\/\/doi.org\/10.1093\/jnci\/dji401.","journal-title":"J Natl Cancer Inst"},{"key":"2067_CR31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1126\/science.7200261","volume":"216","author":"MA Visintainer","year":"1982","unstructured":"Visintainer MA, Volpicelli JR, Seligman ME. Tumor rejection in rats after inescapable or escapable shock. Science. 1982;216:437\u20139. https:\/\/doi.org\/10.1126\/science.7200261.","journal-title":"Science"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.109924","volume":"205","author":"LS Sklar","year":"1979","unstructured":"Sklar LS, Anisman H. Stress and coping factors influence tumor growth. Science. 1979;205:513\u20135. https:\/\/doi.org\/10.1126\/science.109924.","journal-title":"Science"},{"key":"2067_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/21556660.2020.1782414","volume":"9","author":"I Stavropoulos","year":"2020","unstructured":"Stavropoulos I, Sarantopoulos A, Liverezas A. Does sympathetic nervous system modulate tumor progression? A narrative review of the literature. J Drug Assess. 2020;9:106\u201316. https:\/\/doi.org\/10.1080\/21556660.2020.1782414.","journal-title":"J Drug Assess"},{"key":"2067_CR34","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1158\/0008-5472.Can-08-4289","volume":"69","author":"D Chakroborty","year":"2009","unstructured":"Chakroborty D, Sarkar C, Basu B, Dasgupta PS, Basu S. Catecholamines regulate tumor angiogenesis. Can Res. 2009;69:3727\u201330. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-4289.","journal-title":"Can Res"},{"key":"2067_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200053","volume":"6","author":"AL Aronowitz","year":"2022","unstructured":"Aronowitz AL, Ali SR, Glaun MDE, Amit M. Acetylcholine in carcinogenesis and targeting cholinergic receptors in oncology. Adv Biol. 2022;6: e2200053. https:\/\/doi.org\/10.1002\/adbi.202200053.","journal-title":"Adv Biol"},{"key":"2067_CR36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/cam4.4488","volume":"11","author":"B Mravec","year":"2022","unstructured":"Mravec B. Neurobiology of cancer: definition, historical overview, and clinical implications. Cancer Med. 2022;11:903\u201321. https:\/\/doi.org\/10.1002\/cam4.4488.","journal-title":"Cancer Med"},{"key":"2067_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.688953","volume":"9","author":"Y Liang","year":"2021","unstructured":"Liang Y, Li H, Gan Y, Tu H. Shedding light on the role of neurotransmitters in the microenvironment of pancreatic cancer. Front Cell Dev Biol. 2021;9: 688953. https:\/\/doi.org\/10.3389\/fcell.2021.688953.","journal-title":"Front Cell Dev Biol"},{"key":"2067_CR38","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s13402-023-00821-w","volume":"46","author":"YY Wang","year":"2023","unstructured":"Wang YY, et al. MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K\/AKT\/mTOR pathway. Cell Oncol (Dordrecht, Netherlands). 2023;46:1429\u201344. https:\/\/doi.org\/10.1007\/s13402-023-00821-w.","journal-title":"Cell Oncol (Dordrecht, Netherlands)"},{"key":"2067_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41419-022-04799-5","volume":"13","author":"T Qin","year":"2022","unstructured":"Qin T, et al. HGF\/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR\/NGF axis. Cell Death Dis. 2022;13:387. https:\/\/doi.org\/10.1038\/s41419-022-04799-5.","journal-title":"Cell Death Dis"},{"key":"2067_CR40","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1096\/fba.2021-00080","volume":"3","author":"H Hondermarck","year":"2021","unstructured":"Hondermarck H, Huang PS, Wagner JA. The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunity. FASEB bioAdvances. 2021;3:944\u201352. https:\/\/doi.org\/10.1096\/fba.2021-00080.","journal-title":"FASEB bioAdvances"},{"key":"2067_CR41","doi-asserted-by":"crossref","unstructured":"Wang X, Zhang D, Wang MJ. Genomic analyses identify significant biological processes in DDX21-mediated colorectal cancer cells. 2028.489934 (2022).","DOI":"10.1101\/2022.04.28.489934"},{"key":"2067_CR42","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1158\/0008-5472.Can-16-1701","volume":"78","author":"JK Allen","year":"2018","unstructured":"Allen JK, et al. Sustained adrenergic signaling promotes intratumoral innervation through BDNF induction. Can Res. 2018;78:3233\u201342. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-1701.","journal-title":"Can Res"},{"key":"2067_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165586","volume":"11","author":"AA Bapat","year":"2016","unstructured":"Bapat AA, Munoz RM, Von Hoff DD, Han H. Blocking nerve growth factor signaling reduces the neural invasion potential of pancreatic cancer cells. PLoS ONE. 2016;11: e0165586. https:\/\/doi.org\/10.1371\/journal.pone.0165586.","journal-title":"PLoS ONE"},{"key":"2067_CR44","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/2159-8290.Cd-18-0046","volume":"8","author":"BW Renz","year":"2018","unstructured":"Renz BW, et al. Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness. Cancer Discov. 2018;8:1458\u201373. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-0046.","journal-title":"Cancer Discov"},{"key":"2067_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12672-023-00776-2","volume":"14","author":"R Zou","year":"2023","unstructured":"Zou R, et al. Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism. Disc Oncol. 2023;14:162. https:\/\/doi.org\/10.1007\/s12672-023-00776-2.","journal-title":"Disc Oncol"},{"key":"2067_CR46","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3892\/ijmm.2018.4028","volume":"43","author":"W Li","year":"2019","unstructured":"Li W, et al. ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways. Int J Mol Med. 2019;43:914\u201326. https:\/\/doi.org\/10.3892\/ijmm.2018.4028.","journal-title":"Int J Mol Med"},{"key":"2067_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2018.00149","volume":"9","author":"J Cheng","year":"2018","unstructured":"Cheng J, et al. The role of mst1 in lymphocyte homeostasis and function. Front Immunol. 2018;9:149. https:\/\/doi.org\/10.3389\/fimmu.2018.00149.","journal-title":"Front Immunol"},{"key":"2067_CR48","doi-asserted-by":"crossref","unstructured":"Fj\u00e6stad KY. et al. Propranolol reduces sarcoma growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. (2021).","DOI":"10.1101\/2021.03.11.434711"},{"key":"2067_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/coc.0000000000001134","author":"S Lehrer","year":"2024","unstructured":"Lehrer S, Rheinstein PH. Salbutamol, a short acting beta-2 agonist, reduces risk and improves prognosis of prostate cancer. Am J Clin Oncol. 2024. https:\/\/doi.org\/10.1097\/coc.0000000000001134.","journal-title":"Am J Clin Oncol"},{"key":"2067_CR50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1517\/13543784.2013.825250","volume":"22","author":"AS Nagaraja","year":"2013","unstructured":"Nagaraja AS, Sadaoui NC, Lutgendorf SK, Ramondetta LM, Sood AK. \u03b2-blockers: a new role in cancer chemotherapy? Expert Opin Investig Drugs. 2013;22:1359\u201363. https:\/\/doi.org\/10.1517\/13543784.2013.825250.","journal-title":"Expert Opin Investig Drugs"},{"key":"2067_CR51","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","volume":"41","author":"KY Fj\u00e6stad","year":"2022","unstructured":"Fj\u00e6stad KY, et al. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene. 2022;41:1364\u201375. https:\/\/doi.org\/10.1038\/s41388-021-02170-0.","journal-title":"Oncogene"},{"key":"2067_CR52","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.7150\/jca.46556","volume":"11","author":"S Zhao","year":"2020","unstructured":"Zhao S, et al. Propranolol induced apoptosis and autophagy via the ROS\/JNK signaling pathway in Human Ovarian Cancer. J Cancer. 2020;11:5900\u201310. https:\/\/doi.org\/10.7150\/jca.46556.","journal-title":"J Cancer"},{"key":"2067_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120476","author":"CT Lucido","year":"2018","unstructured":"Lucido CT, Miskimins WK, Vermeer PD. Propranolol promotes glucose dependence and synergizes with dichloroacetate for anti-cancer activity in HNSCC. Cancers. 2018. https:\/\/doi.org\/10.3390\/cancers10120476.","journal-title":"Cancers"},{"key":"2067_CR54","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1136\/bmj.308.6935.992","volume":"308","author":"J Kenny","year":"1994","unstructured":"Kenny J. Treating overdose with calcium channel blockers. BMJ (Clinical research ed). 1994;308:992\u20133. https:\/\/doi.org\/10.1136\/bmj.308.6935.992.","journal-title":"BMJ (Clinical research ed)"},{"key":"2067_CR55","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00424-014-1444-z","volume":"466","author":"B Dziegielewska","year":"2014","unstructured":"Dziegielewska B, Gray LS, Dziegielewski J. T-type calcium channels blockers as new tools in cancer therapies. Pflugers Arch. 2014;466:801\u201310. https:\/\/doi.org\/10.1007\/s00424-014-1444-z.","journal-title":"Pflugers Arch"},{"key":"2067_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186490","volume":"12","author":"JH Kim","year":"2017","unstructured":"Kim JH, et al. Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells. PLoS ONE. 2017;12: e0186490. https:\/\/doi.org\/10.1371\/journal.pone.0186490.","journal-title":"PLoS ONE"},{"key":"2067_CR57","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1253\/circj.72.764","volume":"72","author":"B Takase","year":"2008","unstructured":"Takase B, et al. Comparative effects of amlodipine monotherapy and combination therapy with betaxolol on cardiac autonomic nervous activity and health-related quality of life in patients with poorly controlled hypertension. Circ J. 2008;72:764\u20139. https:\/\/doi.org\/10.1253\/circj.72.764.","journal-title":"Circ J"},{"key":"2067_CR58","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/bjc.2014.431","volume":"111","author":"P Jiang","year":"2014","unstructured":"Jiang P, et al. In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. Br J Cancer. 2014;111:1562\u201371. https:\/\/doi.org\/10.1038\/bjc.2014.431.","journal-title":"Br J Cancer"},{"key":"2067_CR59","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3892\/ijo.2011.1273","volume":"40","author":"C Spampanato","year":"2012","unstructured":"Spampanato C, et al. Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression. Int J Oncol. 2012;40:935\u201341. https:\/\/doi.org\/10.3892\/ijo.2011.1273.","journal-title":"Int J Oncol"},{"key":"2067_CR60","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/dc09-2359","volume":"33","author":"M Kivim\u00e4ki","year":"2010","unstructured":"Kivim\u00e4ki M, et al. Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal modeling study. Diabetes Care. 2010;33:1471\u20136. https:\/\/doi.org\/10.2337\/dc09-2359.","journal-title":"Diabetes Care"},{"key":"2067_CR61","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/01.AOG.0000157113.98061.eb","volume":"105","author":"PG Moorman","year":"2005","unstructured":"Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Antidepressant medication use [corrected] and risk of ovarian cancer. Obstet Gynecol. 2005;105:725\u201330. https:\/\/doi.org\/10.1097\/01.AOG.0000157113.98061.eb.","journal-title":"Obstet Gynecol"},{"key":"2067_CR62","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ijc.25322","volume":"128","author":"J Chubak","year":"2011","unstructured":"Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer. 2011;128:227\u201332. https:\/\/doi.org\/10.1002\/ijc.25322.","journal-title":"Int J Cancer"},{"key":"2067_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/Clep.S241249","volume":"12","author":"LAM Berge","year":"2020","unstructured":"Berge LAM, et al. Use of antidepressants and risk of cutaneous melanoma: a prospective registry-based case-control study. Clin Epidemiol. 2020;12:193\u2013202. https:\/\/doi.org\/10.2147\/Clep.S241249.","journal-title":"Clin Epidemiol"},{"key":"2067_CR64","doi-asserted-by":"publisher","first-page":"11687","DOI":"10.18632\/oncotarget.7049","volume":"7","author":"CM Chung","year":"2016","unstructured":"Chung CM, et al. Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested case-control studies. Oncotarget. 2016;7:11687\u201395. https:\/\/doi.org\/10.18632\/oncotarget.7049.","journal-title":"Oncotarget"},{"key":"2067_CR65","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/ijc.30919","volume":"141","author":"LS M\u00f8rch","year":"2017","unstructured":"M\u00f8rch LS, Dehlendorff C, Baandrup L, Friis S, Kjaer SK. Use of antidepressants and risk of epithelial ovarian cancer. Int J Cancer. 2017;141:2197\u2013203. https:\/\/doi.org\/10.1002\/ijc.30919.","journal-title":"Int J Cancer"},{"key":"2067_CR66","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s10552-022-01623-5","volume":"33","author":"R Haque","year":"2022","unstructured":"Haque R, Reading S, Irwin MR, Chen LH, Slezak J. Antidepressant medication use and prostate cancer recurrence in men with depressive disorders. Cancer Causes Control. 2022;33:1363\u201372. https:\/\/doi.org\/10.1007\/s10552-022-01623-5.","journal-title":"Cancer Causes Control"},{"key":"2067_CR67","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/1055-9965.Epi-17-1035","volume":"27","author":"JF Kiridly-Calderbank","year":"2018","unstructured":"Kiridly-Calderbank JF, Sturgeon SR, Kroenke CH, Reeves KW. Antidepressant use and risk of colorectal cancer in the women\u2019s health initiative. Cancer Epidemiol Biomark Prev. 2018;27:892\u20138. https:\/\/doi.org\/10.1158\/1055-9965.Epi-17-1035.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2067_CR68","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.32579","volume":"6","author":"KL Huang","year":"2023","unstructured":"Huang KL, Chen YL, Stewart R, Chen VC. Antidepressant use and mortality among patients with hepatocellular carcinoma. JAMA Netw Open. 2023;6: e2332579. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.32579.","journal-title":"JAMA Netw Open"},{"key":"2067_CR69","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pds.1808","volume":"18","author":"PF Coogan","year":"2009","unstructured":"Coogan PF, Strom BL, Rosenberg L. Antidepressant use and colorectal cancer risk. Pharmacoepidemiol Drug Saf. 2009;18:1111\u20134. https:\/\/doi.org\/10.1002\/pds.1808.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2067_CR70","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1177\/10600280221143512","volume":"57","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Antidepressants and risk of liver cancer: a systematic review and meta-analysis. Ann Pharmacother. 2023;57:1398\u2013409. https:\/\/doi.org\/10.1177\/10600280221143512.","journal-title":"Ann Pharmacother"},{"key":"2067_CR71","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ijc.33307","volume":"148","author":"MJ Lee","year":"2021","unstructured":"Lee MJ, Huang CW, Chen YL, Yang YH, Chen VC. Association between selective serotonin reuptake inhibitors and kidney cancer risk: a nationwide population-based cohort study. Int J Cancer. 2021;148:1331\u20137. https:\/\/doi.org\/10.1002\/ijc.33307.","journal-title":"Int J Cancer"},{"key":"2067_CR72","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1002\/cam4.2329","volume":"8","author":"YH Hsieh","year":"2019","unstructured":"Hsieh YH, et al. Antipsychotic use is inversely associated with gastric cancer risk: a nationwide population-based nested case-control study. Cancer Med. 2019;8:4484\u201396. https:\/\/doi.org\/10.1002\/cam4.2329.","journal-title":"Cancer Med"},{"key":"2067_CR73","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/cac2.12242","volume":"42","author":"J Li","year":"2022","unstructured":"Li J, Tang F, Si S, Xue F. Association between antipsychotic agents and risk of lung cancer: a nested case-control study. Cancer Commun. 2022;42:175\u20138. https:\/\/doi.org\/10.1002\/cac2.12242.","journal-title":"Cancer Commun"},{"key":"2067_CR74","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s43856-023-00364-z","volume":"3","author":"Y Chai","year":"2023","unstructured":"Chai Y, et al. Association between cumulative exposure periods of flupentixol or any antipsychotics and risk of lung cancer. Commun Med. 2023;3:126. https:\/\/doi.org\/10.1038\/s43856-023-00364-z.","journal-title":"Commun Med"},{"key":"2067_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/CEJ.0b013e32834a7e6f","volume":"21","author":"M Stettner","year":"2012","unstructured":"Stettner M, et al. Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer. Euro J Cancer Prev. 2012;21:55\u201364. https:\/\/doi.org\/10.1097\/CEJ.0b013e32834a7e6f.","journal-title":"Euro J Cancer Prev"},{"key":"2067_CR76","doi-asserted-by":"publisher","first-page":"16758","DOI":"10.1038\/srep16758","volume":"5","author":"C Fairhurst","year":"2015","unstructured":"Fairhurst C, Watt I, Martin F, Bland M, Brackenbury WJ. Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study. Sci Rep. 2015;5:16758. https:\/\/doi.org\/10.1038\/srep16758.","journal-title":"Sci Rep"},{"key":"2067_CR77","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1177\/1535370213493721","volume":"238","author":"AM Bielecka","year":"2013","unstructured":"Bielecka AM, Obuchowicz EJE. Antidepressant drugs as a complementary therapeutic strategy in cancer. Exper Biol Med. 2013;238:849\u201358.","journal-title":"Exper Biol Med"},{"key":"2067_CR78","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/lt.26258","volume":"28","author":"HL Lee","year":"2022","unstructured":"Lee HL, et al. Anticancer effect of statins in patients undergoing liver transplantation for hepatocellular carcinoma. Liver Transpl. 2022;28:397\u2013406. https:\/\/doi.org\/10.1002\/lt.26258.","journal-title":"Liver Transpl"},{"key":"2067_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13046-021-02041-2","volume":"40","author":"W Jiang","year":"2021","unstructured":"Jiang W, Hu JW, He XR, Jin WL, He XY. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res. 2021;40:241. https:\/\/doi.org\/10.1186\/s13046-021-02041-2.","journal-title":"J Exp Clin Cancer Res"},{"key":"2067_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7100325","author":"HJ Jang","year":"2018","unstructured":"Jang HJ, Kim HS, Kim JH, Lee J. The effect of statin added to systemic anticancer therapy: a meta-analysis of randomized, controlled trials. J Clin Med. 2018. https:\/\/doi.org\/10.3390\/jcm7100325.","journal-title":"J Clin Med"},{"key":"2067_CR81","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler F, et al. Cancer neuroscience: State of the field, emerging directions. Cell. 2023;186:1689\u2013707. https:\/\/doi.org\/10.1016\/j.cell.2023.02.002.","journal-title":"Cell"},{"key":"2067_CR82","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3332\/ecancer.2018.886","volume":"12","author":"P Pantziarka","year":"2018","unstructured":"Pantziarka P, et al. ReDO_DB: the repurposing drugs in oncology database. Ecancermedicalscience. 2018;12:886. https:\/\/doi.org\/10.3332\/ecancer.2018.886.","journal-title":"Ecancermedicalscience"},{"key":"2067_CR83","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2019.v12i2.29097","author":"AL Priya","year":"2019","unstructured":"Priya AL, Chellathai KDH, Mohan YJ. Evaluation and comparison of cytotoxic effect of vilazodone hydrochloride with 5-fluorouracil in Ht-29 bowel cancer cell line. Asian J Pharmaceut Clin Res. 2019. https:\/\/doi.org\/10.22159\/ajpcr.2019.v12i2.29097.","journal-title":"Asian J Pharmaceut Clin Res"},{"key":"2067_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/bioe.2019.0013","volume":"1","author":"SL Payne","year":"2019","unstructured":"Payne SL, Levin M, Oudin MJ. Bioelectric control of metastasis in solid tumors. Bioelectricity. 2019;1:114\u201330. https:\/\/doi.org\/10.1089\/bioe.2019.0013.","journal-title":"Bioelectricity"},{"key":"2067_CR85","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1111\/jcmm.15022","volume":"24","author":"FT Hsu","year":"2020","unstructured":"Hsu FT, Chiang IT, Wang WS. Induction of apoptosis through extrinsic\/intrinsic pathways and suppression of ERK\/NF-\u03baB signalling participate in anti-glioblastoma of imipramine. J Cell Mol Med. 2020;24:3982\u20134000. https:\/\/doi.org\/10.1111\/jcmm.15022.","journal-title":"J Cell Mol Med"},{"key":"2067_CR86","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/2159-8290.Cd-13-0183","volume":"3","author":"NS Jahchan","year":"2013","unstructured":"Jahchan NS, et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov. 2013;3:1364\u201377. https:\/\/doi.org\/10.1158\/2159-8290.Cd-13-0183.","journal-title":"Cancer Discov"},{"key":"2067_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101513","author":"D Duarte","year":"2022","unstructured":"Duarte D, Vale N. Antidepressant drug sertraline against human cancer cells. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12101513.","journal-title":"Biomolecules"},{"key":"2067_CR88","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.18632\/oncotarget.3243","volume":"6","author":"KH Liu","year":"2015","unstructured":"Liu KH, et al. Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis. Oncotarget. 2015;6:5088\u2013101. https:\/\/doi.org\/10.18632\/oncotarget.3243.","journal-title":"Oncotarget"},{"key":"2067_CR89","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.21873\/anticanres.12843","volume":"38","author":"JY Wu","year":"2018","unstructured":"Wu JY, Lin SS, Hsu FT, Chung JG. Fluoxetine inhibits DNA repair and NF-\u0138B-modulated metastatic potential in non-small cell lung cancer. Anticancer Res. 2018;38:5201\u201310. https:\/\/doi.org\/10.21873\/anticanres.12843.","journal-title":"Anticancer Res"},{"key":"2067_CR90","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/cad.0000000000001067","volume":"32","author":"H Zhang","year":"2021","unstructured":"Zhang H, Xu H, Tang Q, Bi F. The selective serotonin reuptake inhibitors enhance the cytotoxicity of sorafenib in hepatocellular carcinoma cells. Anticancer Drugs. 2021;32:793\u2013801. https:\/\/doi.org\/10.1097\/cad.0000000000001067.","journal-title":"Anticancer Drugs"},{"key":"2067_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.676239","volume":"12","author":"M Ostadkarampour","year":"2021","unstructured":"Ostadkarampour M, Putnins EE. Monoamine oxidase inhibitors: a review of their anti-inflammatory therapeutic potential and mechanisms of action. Front Pharmacol. 2021;12: 676239. https:\/\/doi.org\/10.3389\/fphar.2021.676239.","journal-title":"Front Pharmacol"},{"key":"2067_CR92","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/aps.2017.24","volume":"38","author":"J Li","year":"2017","unstructured":"Li J, et al. Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer. Acta Pharmacol Sin. 2017;38:1282\u201396. https:\/\/doi.org\/10.1038\/aps.2017.24.","journal-title":"Acta Pharmacol Sin"},{"key":"2067_CR93","doi-asserted-by":"publisher","first-page":"2592691","DOI":"10.1155\/2023\/2592691","volume":"2023","author":"A Alkhawaldeh","year":"2023","unstructured":"Alkhawaldeh A, Bardaweel S. Molecular investigation of the antitumor effects of monoamine oxidase inhibitors in breast cancer cells. Biomed Res Int. 2023;2023:2592691. https:\/\/doi.org\/10.1155\/2023\/2592691.","journal-title":"Biomed Res Int"},{"key":"2067_CR94","doi-asserted-by":"publisher","first-page":"1068277","DOI":"10.3389\/fpsyt.2023.1068277","volume":"14","author":"F Akbarzadeh","year":"2023","unstructured":"Akbarzadeh F, et al. The effect of adding curcumin to sodium valproate in treatment of patients with bipolar disorder in the acute phase of mania: a randomized double-blind clinical trial. Front Psych. 2023;14:1068277. https:\/\/doi.org\/10.3389\/fpsyt.2023.1068277.","journal-title":"Front Psych"},{"key":"2067_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.schres.2011.02.018","volume":"129","author":"FH Chou","year":"2011","unstructured":"Chou FH, Tsai KY, Su CY, Lee CC. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res. 2011;129:97\u2013103. https:\/\/doi.org\/10.1016\/j.schres.2011.02.018.","journal-title":"Schizophr Res"},{"key":"2067_CR96","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/15384047.2020.1726718","volume":"21","author":"S Dees","year":"2020","unstructured":"Dees S, Pontiggia L, Jasmin JF, Mercier I. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer. Cancer Biol Ther. 2020;21:506\u201321. https:\/\/doi.org\/10.1080\/15384047.2020.1726718.","journal-title":"Cancer Biol Ther"},{"key":"2067_CR97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcancer.2019.10.007","volume":"68","author":"V Shaw","year":"2021","unstructured":"Shaw V, Srivastava S, Srivastava SK. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy. Semin Cancer Biol. 2021;68:75\u201383. https:\/\/doi.org\/10.1016\/j.semcancer.2019.10.007.","journal-title":"Semin Cancer Biol"},{"key":"2067_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010137","author":"B R\u00e1cz","year":"2023","unstructured":"R\u00e1cz B, Spengler G. Repurposing antidepressants and phenothiazine antipsychotics as efflux pump inhibitors in cancer and infectious diseases. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12010137.","journal-title":"Antibiotics"},{"key":"2067_CR99","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12964-022-00882-8","volume":"20","author":"J Hu","year":"2022","unstructured":"Hu J, et al. Inhibition of AMPK\/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth. Cell Commun Signal. 2022;20:105. https:\/\/doi.org\/10.1186\/s12964-022-00882-8.","journal-title":"Cell Commun Signal"},{"key":"2067_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1570159x17666191010094849","volume":"18","author":"FC Kong","year":"2020","unstructured":"Kong FC, Ma CL, Zhong MK. Epigenetic effects mediated by antiepileptic drugs and their potential application. Curr Neuropharmacol. 2020;18:153\u201366. https:\/\/doi.org\/10.2174\/1570159x17666191010094849.","journal-title":"Curr Neuropharmacol"},{"key":"2067_CR101","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/jnnp.2006.106211","volume":"78","author":"G Singh","year":"2007","unstructured":"Singh G, Rees JH, Sander JW. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J Neurol Neurosurg Psychiatry. 2007;78:342\u20139. https:\/\/doi.org\/10.1136\/jnnp.2006.106211.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2067_CR102","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.1007\/s11033-023-08568-1","volume":"50","author":"M Aroosa","year":"2023","unstructured":"Aroosa M, et al. The evidence for repurposing anti-epileptic drugs to target cancer. Mol Biol Rep. 2023;50:7667\u201380. https:\/\/doi.org\/10.1007\/s11033-023-08568-1.","journal-title":"Mol Biol Rep"},{"key":"2067_CR103","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10616-012-9513-7","volume":"65","author":"X Liu","year":"2013","unstructured":"Liu X, Chen L, Sun F, Zhang G. Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action. Cytotechnology. 2013;65:597\u2013608. https:\/\/doi.org\/10.1007\/s10616-012-9513-7.","journal-title":"Cytotechnology"},{"key":"2067_CR104","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.3892\/ol.2017.5792","volume":"13","author":"DW Choo","year":"2017","unstructured":"Choo DW, et al. CHK2 is involved in the p53-independent radiosensitizing effects of valproic acid. Oncol Lett. 2017;13:2591\u20138. https:\/\/doi.org\/10.3892\/ol.2017.5792.","journal-title":"Oncol Lett"},{"key":"2067_CR105","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s10495-009-0384-0","volume":"14","author":"Y Arakawa","year":"2009","unstructured":"Arakawa Y, Saito S, Yamada H, Aiba K. Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-X(L) and promotes apoptosis of MCF-7 breast cancer cells. Apoptosis. 2009;14:1076\u201385. https:\/\/doi.org\/10.1007\/s10495-009-0384-0.","journal-title":"Apoptosis"},{"key":"2067_CR106","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/08830738050200070801","volume":"20","author":"N Kabakus","year":"2005","unstructured":"Kabakus N, et al. Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats. J Child Neurol. 2005;20:582\u20137. https:\/\/doi.org\/10.1177\/08830738050200070801.","journal-title":"J Child Neurol"},{"key":"2067_CR107","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1532-5415.1995.tb06392.x","volume":"43","author":"D Robinson","year":"1995","unstructured":"Robinson D, Langer A, Casso D, Fenn H, Yesavage J. Pancytopenia and valproic acid\u2013a possible association. J Am Geriatr Soc. 1995;43:198. https:\/\/doi.org\/10.1111\/j.1532-5415.1995.tb06392.x.","journal-title":"J Am Geriatr Soc"},{"key":"2067_CR108","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.4161\/cbt.6.9.4567","volume":"6","author":"FA de Jong","year":"2007","unstructured":"de Jong FA, et al. Irinotecan chemotherapy during valproic acid treatment: pharmacokinetic interaction and hepatotoxicity. Cancer Biol Ther. 2007;6:1368\u201374. https:\/\/doi.org\/10.4161\/cbt.6.9.4567.","journal-title":"Cancer Biol Ther"},{"key":"2067_CR109","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/jcmm.14011","volume":"23","author":"WJ Jang","year":"2019","unstructured":"Jang WJ, Jung SK, Vo TTL, Jeong CH. Anticancer activity of paroxetine in human colon cancer cells: involvement of MET and ERBB3. J Cell Mol Med. 2019;23:1106\u201315. https:\/\/doi.org\/10.1111\/jcmm.14011.","journal-title":"J Cell Mol Med"},{"key":"2067_CR110","doi-asserted-by":"publisher","first-page":"e201148","DOI":"10.1590\/s2175-97902022e201148","volume":"58","author":"YD Cakil","year":"2022","unstructured":"Cakil YD, Ozunal ZG, Kayali DG, Aktas RG, Saglam EJBJ. Anti-proliferative effects of paroxetine alone or in combination with sorafenib in HepG2 cells. Brazilian J Pharmaceut Sci. 2022;58:e201148.","journal-title":"Brazilian J Pharmaceut Sci"},{"key":"2067_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010064","author":"YW Cho","year":"2019","unstructured":"Cho YW, et al. Paroxetine induces apoptosis of human breast cancer MCF-7 cells through Ca(2+)-and p38 MAP kinase-dependent ROS generation. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11010064.","journal-title":"Cancers"},{"key":"2067_CR112","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fcell.2019.00397","volume":"7","author":"K Wang","year":"2019","unstructured":"Wang K, et al. Blockage of autophagic flux and induction of mitochondria fragmentation by paroxetine hydrochloride in lung cancer cells promotes apoptosis via the ROS-MAPK pathway. Front Cell Dev Biol. 2019;7:397. https:\/\/doi.org\/10.3389\/fcell.2019.00397.","journal-title":"Front Cell Dev Biol"},{"key":"2067_CR113","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.3390\/ijms19103260","volume":"19","author":"J Walory","year":"2018","unstructured":"Walory J, et al. Oncotoxic properties of serotonin transporter inhibitors and 5-HT1A receptor ligands. Int J Mol Sci. 2018;19:3260.","journal-title":"Int J Mol Sci"},{"key":"2067_CR114","doi-asserted-by":"publisher","first-page":"120","DOI":"10.62400\/jbs.v5i1.6389","volume":"5","author":"FA Khodashahri","year":"2022","unstructured":"Khodashahri FA, Zargarnezhad M, Sajadi RJJ. The cytotoxic effects of sertraline on ovarian (A2780) cancer cells in vitro. J Biol Stud. 2022;5:120\u20137.","journal-title":"J Biol Stud"},{"key":"2067_CR115","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/bjc.2017.230","volume":"117","author":"M Boia-Ferreira","year":"2017","unstructured":"Boia-Ferreira M, et al. TCTP as a therapeutic target in melanoma treatment. Br J Cancer. 2017;117:656\u201365. https:\/\/doi.org\/10.1038\/bjc.2017.230.","journal-title":"Br J Cancer"},{"key":"2067_CR116","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-021-01971-1","volume":"40","author":"D Ye","year":"2021","unstructured":"Ye D, et al. Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment. J Exp Clin Cancer Res. 2021;40:173. https:\/\/doi.org\/10.1186\/s13046-021-01971-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"2067_CR117","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1158\/0008-5472.Can-09-4072","volume":"70","author":"CJ Lin","year":"2010","unstructured":"Lin CJ, Robert F, Sukarieh R, Michnick S, Pelletier J. The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling. Can Res. 2010;70:3199\u2013208. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-4072.","journal-title":"Can Res"},{"key":"2067_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411852","author":"CY Hsu","year":"2023","unstructured":"Hsu CY, et al. Sertindole, an antipsychotic drug, curbs the STAT3\/BCL-xL axis to elicit human bladder cancer cell apoptosis in vitro. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241411852.","journal-title":"Int J Mol Sci"},{"key":"2067_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1287358","volume":"58","author":"D Xia","year":"2017","unstructured":"Xia D, et al. Sertraline exerts its antitumor functions through both apoptosis and autophagy pathways in acute myeloid leukemia cells. Leuk Lymphoma. 2017;58:1\u201310. https:\/\/doi.org\/10.1080\/10428194.2017.1287358.","journal-title":"Leuk Lymphoma"},{"key":"2067_CR120","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3892\/ijo_00000756","volume":"37","author":"S Tzadok","year":"2010","unstructured":"Tzadok S, et al. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. Int J Oncol. 2010;37:1043\u201351. https:\/\/doi.org\/10.3892\/ijo_00000756.","journal-title":"Int J Oncol"},{"key":"2067_CR121","first-page":"2043","volume":"10","author":"S Chinnapaka","year":"2020","unstructured":"Chinnapaka S, Bakthavachalam V, Munirathinam G. Repurposing antidepressant sertraline as a pharmacological drug to target prostate cancer stem cells: dual activation of apoptosis and autophagy signaling by deregulating redox balance. Am J Cancer Res. 2020;10:2043\u201365.","journal-title":"Am J Cancer Res"},{"key":"2067_CR122","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3906\/biy-1802-11","volume":"42","author":"A Biber","year":"2018","unstructured":"Biber A, Durusu \u0130. In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma. Turkish J Biol Turk Biyol Dergisi. 2018;42:414\u201321. https:\/\/doi.org\/10.3906\/biy-1802-11.","journal-title":"Turkish J Biol Turk Biyol Dergisi"},{"key":"2067_CR123","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejphar.2015.06.007","volume":"761","author":"SY Yuan","year":"2015","unstructured":"Yuan SY, et al. Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo. Eur J Pharmacol. 2015;761:309\u201320. https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.007.","journal-title":"Eur J Pharmacol"},{"key":"2067_CR124","doi-asserted-by":"publisher","first-page":"17445","DOI":"10.1002\/cam4.6316","volume":"12","author":"Z Wan","year":"2023","unstructured":"Wan Z, et al. Identification of angiogenesis-related genes signature for predicting survival and its regulatory network in glioblastoma. Cancer Med. 2023;12:17445\u201367. https:\/\/doi.org\/10.1002\/cam4.6316.","journal-title":"Cancer Med"},{"key":"2067_CR125","doi-asserted-by":"publisher","DOI":"10.1172\/jci152067","author":"W Zhang","year":"2021","unstructured":"Zhang W, et al. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci152067.","journal-title":"J Clin Invest"},{"key":"2067_CR126","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025246","volume":"9","author":"LAM Berge","year":"2019","unstructured":"Berge LAM, et al. Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study. BMJ Open. 2019;9: e025246. https:\/\/doi.org\/10.1136\/bmjopen-2018-025246.","journal-title":"BMJ Open"},{"key":"2067_CR127","doi-asserted-by":"publisher","first-page":"74","DOI":"10.20892\/j.issn.2095-3941.2020.0218","volume":"19","author":"X Cheng","year":"2021","unstructured":"Cheng X, et al. Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network. Cancer Biol Med. 2021;19:74\u201389. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0218.","journal-title":"Cancer Biol Med"},{"key":"2067_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.904701","volume":"13","author":"S Shao","year":"2022","unstructured":"Shao S, Zhuang X, Zhang L, Qiao T. Antidepressants fluoxetine mediates endoplasmic reticulum stress and autophagy of non-small cell lung cancer cells through the ATF4-AKT-mTOR signaling pathway. Front Pharmacol. 2022;13: 904701. https:\/\/doi.org\/10.3389\/fphar.2022.904701.","journal-title":"Front Pharmacol"},{"key":"2067_CR129","doi-asserted-by":"publisher","first-page":"1085569","DOI":"10.3389\/fonc.2023.1085569","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, et al. High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer. Front Oncol. 2023;13:1085569. https:\/\/doi.org\/10.3389\/fonc.2023.1085569.","journal-title":"Front Oncol"},{"key":"2067_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172441","volume":"857","author":"M Marcinkute","year":"2019","unstructured":"Marcinkute M, Afshinjavid S, Fatokun AA, Javid FA. Fluoxetine selectively induces p53-independent apoptosis in human colorectal cancer cells. Eur J Pharmacol. 2019;857: 172441. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172441.","journal-title":"Eur J Pharmacol"},{"key":"2067_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030757","author":"WT Chen","year":"2019","unstructured":"Chen WT, et al. Fluoxetine induces apoptosis through extrinsic\/intrinsic pathways and inhibits ERK\/NF-\u03baB-modulated anti-apoptotic and invasive potential in hepatocellular carcinoma cells in vitro. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20030757.","journal-title":"Int J Mol Sci"},{"key":"2067_CR132","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.21873\/anticanres.13823","volume":"39","author":"TM Khing","year":"2019","unstructured":"Khing TM, Po WW, Sohn UD. Fluoxetine enhances anti-tumor activity of paclitaxel in gastric adenocarcinoma cells by triggering apoptosis and necroptosis. Anticancer Res. 2019;39:6155\u201363. https:\/\/doi.org\/10.21873\/anticanres.13823.","journal-title":"Anticancer Res"},{"key":"2067_CR133","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1158\/1538-7445.AM2022-5401","volume":"82","author":"P Tan","year":"2022","unstructured":"Tan P, Hsu F-T, Chiang I-T, Chang YJCR. Fluoxetine inhibit osteosarcoma progression via RANK\/RANKL signaling pathway. Cancer Res. 2022;82:5401\u20135401.","journal-title":"Cancer Res"},{"key":"2067_CR134","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1158\/1538-7445.AM2022-5285","volume":"82","author":"Z-L Tan","year":"2022","unstructured":"Tan Z-L, Chang Y, Chiang I-T, Hsu F-T, Hsu F-TJCR. Antitumor and mechanism of selective serotonin reuptake inhibitor fluoxetine on muscle invasive bladder cancer. Cancer Res. 2022;82:5285\u20135285.","journal-title":"Cancer Res"},{"key":"2067_CR135","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8095","author":"KMA Zinnah","year":"2021","unstructured":"Zinnah KMA, Park SY. Sensitizing TRAIL-resistant A549 lung cancer cells and enhancing TRAIL-induced apoptosis with the antidepressant amitriptyline. Oncol Rep. 2021. https:\/\/doi.org\/10.3892\/or.2021.8095.","journal-title":"Oncol Rep"},{"key":"2067_CR136","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fphar.2018.00218","volume":"9","author":"SK Tan","year":"2018","unstructured":"Tan SK, et al. Drug repositioning in glioblastoma: a pathway perspective. Front Pharmacol. 2018;9:218. https:\/\/doi.org\/10.3389\/fphar.2018.00218.","journal-title":"Front Pharmacol"},{"key":"2067_CR137","doi-asserted-by":"publisher","first-page":"07","DOI":"10.1158\/1538-7445.SABCS22-P3-07-19","volume":"83","author":"PP Venkata","year":"2023","unstructured":"Venkata PP, et al. Abstract P3\u201307\u201319: anti-depressant amitriptyline augments the efficacy of tamoxifen in ER positive breast cancer. Can Res. 2023;83:07\u201319.","journal-title":"Can Res"},{"key":"2067_CR138","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.7314\/apjcp.2012.13.10.4897","volume":"13","author":"M Bilici","year":"2012","unstructured":"Bilici M, et al. Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats. Asian Pacific J Cancer Prev. 2012;13:4897\u2013900. https:\/\/doi.org\/10.7314\/apjcp.2012.13.10.4897.","journal-title":"Asian Pacific J Cancer Prev"},{"key":"2067_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038886","volume":"7","author":"CK Fang","year":"2012","unstructured":"Fang CK, et al. Mirtazapine inhibits tumor growth via immune response and serotonergic system. PLoS ONE. 2012;7: e38886. https:\/\/doi.org\/10.1371\/journal.pone.0038886.","journal-title":"PLoS ONE"},{"key":"2067_CR140","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/s1734-1140(13)71045-4","volume":"65","author":"B Grygier","year":"2013","unstructured":"Grygier B, et al. Inhibitory effect of antidepressants on B16F10 melanoma tumor growth. Pharmacol Rep. 2013;65:672\u201381. https:\/\/doi.org\/10.1016\/s1734-1140(13)71045-4.","journal-title":"Pharmacol Rep"},{"key":"2067_CR141","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3892\/or.2017.5723","volume":"38","author":"DK Yang","year":"2017","unstructured":"Yang DK, Kim SJ. Desipramine induces apoptosis in hepatocellular carcinoma cells. Oncol Rep. 2017;38:1029\u201334. https:\/\/doi.org\/10.3892\/or.2017.5723.","journal-title":"Oncol Rep"},{"key":"2067_CR142","doi-asserted-by":"publisher","first-page":"15756","DOI":"10.1002\/jcb.28845","volume":"120","author":"K Qian","year":"2019","unstructured":"Qian K, et al. Trifluoperazine as an alternative strategy for the inhibition of tumor growth of colorectal cancer. J Cell Biochem. 2019;120:15756\u201365. https:\/\/doi.org\/10.1002\/jcb.28845.","journal-title":"J Cell Biochem"},{"key":"2067_CR143","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41419-018-1046-3","volume":"9","author":"Z Feng","year":"2018","unstructured":"Feng Z, et al. The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis. Cell Death Dis. 2018;9:1006. https:\/\/doi.org\/10.1038\/s41419-018-1046-3.","journal-title":"Cell Death Dis"},{"key":"2067_CR144","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","volume":"186","author":"CT Yeh","year":"2012","unstructured":"Yeh CT, et al. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med. 2012;186:1180\u20138. https:\/\/doi.org\/10.1164\/rccm.201207-1180OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133218","author":"KL Kuo","year":"2019","unstructured":"Kuo KL, et al. Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing Bcl-xL: an in vitro and in vivo study. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133218.","journal-title":"Int J Mol Sci"},{"key":"2067_CR146","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1158\/1538-7445.AM2022-3896","volume":"82","author":"S Ramachandran","year":"2022","unstructured":"Ramachandran S, Gaikwad S, Srivastava SKJCR. Pimavanserin suppresses the growth of medulloblastoma by inhibiting Lyn\/STAT3\/MBSC signaling axis. Cancer Res. 2022;82:3896\u20133896.","journal-title":"Cancer Res"},{"key":"2067_CR147","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/1538-7445.AM2020-1218","volume":"80","author":"S Ramachandran","year":"2020","unstructured":"Ramachandran S, Srivastava SKJCR. Pimavanserin induces autophagy mediated apoptosis in pancreatic cancer and suppresses pancreatic tumor growth. Cancer Res. 2020;80:1218\u20131218.","journal-title":"Cancer Res"},{"key":"2067_CR148","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1158\/1538-7445.AM2023-4873","volume":"83","author":"MY Agrawal","year":"2023","unstructured":"Agrawal MY, Ramachandran S, Zabel C, Srivastava SKJCR. Pimavanserin suppresses glioblastoma progression by modulating the Akt\/FOXO\/Bim signaling axis. Cancer Res. 2023;83:4873\u20134873.","journal-title":"Cancer Res"},{"key":"2067_CR149","first-page":"2767","volume":"8","author":"Q Meng","year":"2016","unstructured":"Meng Q, Sun X, Wang J, Wang Y, Wang L. The important application of thioridazine in the endometrial cancer. Am J Trans Res. 2016;8:2767\u201375.","journal-title":"Am J Trans Res"},{"key":"2067_CR150","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3892\/or.2014.3068","volume":"31","author":"J Mu","year":"2014","unstructured":"Mu J, et al. Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer. Oncol Rep. 2014;31:2107\u201314. https:\/\/doi.org\/10.3892\/or.2014.3068.","journal-title":"Oncol Rep"},{"key":"2067_CR151","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/jog.12691","volume":"41","author":"M Mao","year":"2015","unstructured":"Mao M, Yu T, Hu J, Hu L. Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa. J Obstet Gynaecol Res. 2015;41:1240\u20135. https:\/\/doi.org\/10.1111\/jog.12691.","journal-title":"J Obstet Gynaecol Res"},{"key":"2067_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.35","volume":"5","author":"KJ Min","year":"2014","unstructured":"Min KJ, Seo BR, Bae YC, Yoo YH, Kwon TK. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L). Cell Death Dis. 2014;5: e1063. https:\/\/doi.org\/10.1038\/cddis.2014.35.","journal-title":"Cell Death Dis"},{"key":"2067_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091310","author":"H Kim","year":"2019","unstructured":"Kim H, et al. Repurposing penfluridol in combination with temozolomide for the treatment of glioblastoma. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11091310.","journal-title":"Cancers"},{"key":"2067_CR154","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1158\/1538-7445.AM2017-3176","volume":"77","author":"N Gupta","year":"2017","unstructured":"Gupta N, Gupta P, Srivastava SJCR. Inhibition of HER2\/\u03b2-catenin signaling by penfluridol overcomes resistance to paclitaxel in breast cancer. Cancer Res. 2017;77:3176\u20133176.","journal-title":"Cancer Res"},{"key":"2067_CR155","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/1538-7445.AM2013-1291","volume":"73","author":"W Chien","year":"2013","unstructured":"Chien W, et al. Identification of penfluridol as potential treatment for pancreatic cancer cells. Cancer Res. 2013;73:1291\u20131291.","journal-title":"Cancer Res"},{"key":"2067_CR156","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.apsb.2021.09.007","volume":"12","author":"C Zheng","year":"2022","unstructured":"Zheng C, et al. Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK\/FOXO3a\/BIM-dependent manner. Acta pharmaceutica Sinica B. 2022;12:1271\u201387. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.007.","journal-title":"Acta pharmaceutica Sinica B"},{"key":"2067_CR157","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41419-019-1785-9","volume":"10","author":"WY Hung","year":"2019","unstructured":"Hung WY, et al. Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response. Cell Death Dis. 2019;10:538. https:\/\/doi.org\/10.1038\/s41419-019-1785-9.","journal-title":"Cell Death Dis"},{"key":"2067_CR158","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41419-022-04828-3","volume":"13","author":"MC Tung","year":"2022","unstructured":"Tung MC, et al. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis. Cell Death Dis. 2022;13:400. https:\/\/doi.org\/10.1038\/s41419-022-04828-3.","journal-title":"Cell Death Dis"},{"key":"2067_CR159","doi-asserted-by":"publisher","DOI":"10.31487\/j.COR.2020.02.03","author":"F Mongelli","year":"2020","unstructured":"Mongelli F, Mongelli F, Hakeem IJ, Hodges NJ. Cytotoxicity of SH-SY5Y neuroblastoma cells to the antipsychotic drugs, chlorpromazine and trifluoperazine, is via a Ca2 -mediated apoptosis process and differentiation of these cells with retinoic acid makes them more resistant to cell death. Clin Oncol Res. 2020. https:\/\/doi.org\/10.31487\/j.COR.2020.02.03.","journal-title":"Clin Oncol Res"},{"key":"2067_CR160","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3389\/fonc.2019.01423","volume":"9","author":"H Yan","year":"2019","unstructured":"Yan H, et al. PELP1 suppression inhibits gastric cancer through downregulation of c-Src-PI3K-ERK pathway. Front Oncol. 2019;9:1423. https:\/\/doi.org\/10.3389\/fonc.2019.01423.","journal-title":"Front Oncol"},{"key":"2067_CR161","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1158\/0008-5472.Can-07-2235","volume":"67","author":"MS Lee","year":"2007","unstructured":"Lee MS, et al. The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. Can Res. 2007;67:11359\u201367. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-2235.","journal-title":"Can Res"},{"key":"2067_CR162","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41419-023-06353-3","volume":"14","author":"C Abbruzzese","year":"2023","unstructured":"Abbruzzese C, et al. Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2. Cell Death Dis. 2023;14:821. https:\/\/doi.org\/10.1038\/s41419-023-06353-3.","journal-title":"Cell Death Dis"},{"key":"2067_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304203","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. Targeting GRP75 with a chlorpromazine derivative inhibits endometrial cancer progression through GRP75-IP3R-Ca(2+)-AMPK Axis. Advanced science. 2024. https:\/\/doi.org\/10.1002\/advs.202304203.","journal-title":"Advanced science"},{"key":"2067_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020212","author":"MJ Gouveia","year":"2024","unstructured":"Gouveia MJ, Ribeiro E, Vale N. A Surprising repurposing of central nervous system drugs against squamous cell carcinoma of the bladder, UM-UC-5. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16020212.","journal-title":"Pharmaceutics"},{"key":"2067_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.989","volume":"10","author":"HJ Jeong","year":"2022","unstructured":"Jeong HJ, et al. Aripiprazole sensitizes head and neck cancer cells to ionizing radiation by enhancing the production of reactive oxygen species. Pharmacol Res Perspect. 2022;10: e00989. https:\/\/doi.org\/10.1002\/prp2.989.","journal-title":"Pharmacol Res Perspect"},{"key":"2067_CR166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235676","volume":"15","author":"A Badran","year":"2020","unstructured":"Badran A, et al. Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro. PLoS ONE. 2020;15: e0235676. https:\/\/doi.org\/10.1371\/journal.pone.0235676.","journal-title":"PLoS ONE"},{"key":"2067_CR167","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.18632\/oncotarget.26949","volume":"10","author":"S Suzuki","year":"2019","unstructured":"Suzuki S, et al. In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile. Oncotarget. 2019;10:3547\u201358. https:\/\/doi.org\/10.18632\/oncotarget.26949.","journal-title":"Oncotarget"},{"key":"2067_CR168","doi-asserted-by":"publisher","first-page":"15753","DOI":"10.1038\/s41598-018-33740-0","volume":"8","author":"W Zhang","year":"2018","unstructured":"Zhang W, et al. Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastases. Sci Rep. 2018;8:15753. https:\/\/doi.org\/10.1038\/s41598-018-33740-0.","journal-title":"Sci Rep"},{"key":"2067_CR169","doi-asserted-by":"publisher","first-page":"849","DOI":"10.7150\/jca.34847","volume":"11","author":"C Dai","year":"2020","unstructured":"Dai C, et al. The antipsychotic agent sertindole exhibited antiproliferative activities by inhibiting the STAT3 signaling pathway in human gastric cancer cells. J Cancer. 2020;11:849\u201357. https:\/\/doi.org\/10.7150\/jca.34847.","journal-title":"J Cancer"},{"key":"2067_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.41","volume":"2","author":"B Liu","year":"2023","unstructured":"Liu B, et al. Sertindole inhibits autophagic flux and glioma progression. MedComm--Oncology. 2023;2: e41.","journal-title":"MedComm--Oncology"},{"key":"2067_CR171","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.01.042","volume":"393","author":"SJ Dilly","year":"2017","unstructured":"Dilly SJ, et al. A chemical genomics approach to drug reprofiling in oncology: antipsychotic drug risperidone as a potential adenocarcinoma treatment. Cancer Lett. 2017;393:16\u201321. https:\/\/doi.org\/10.1016\/j.canlet.2017.01.042.","journal-title":"Cancer Lett"},{"key":"2067_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061560","author":"VC Chen","year":"2020","unstructured":"Chen VC, et al. New use for old drugs: the protective effect of risperidone on colorectal cancer. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12061560.","journal-title":"Cancers"},{"key":"2067_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.846455","volume":"13","author":"VC Chen","year":"2022","unstructured":"Chen VC, et al. Association of risperidone with gastric cancer: triangulation method from cell study, animal study, and cohort study. Front Pharmacol. 2022;13: 846455. https:\/\/doi.org\/10.3389\/fphar.2022.846455.","journal-title":"Front Pharmacol"},{"key":"2067_CR174","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1158\/0008-5472.Can-21-3882","volume":"82","author":"Y Li","year":"2022","unstructured":"Li Y, et al. TRAF4 maintains deubiquitination of caveolin-1 to drive glioblastoma stemness and temozolomide resistance. Can Res. 2022;82:3573\u201387. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-3882.","journal-title":"Can Res"},{"key":"2067_CR175","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1002\/ijc.31980","volume":"144","author":"VC Chen","year":"2019","unstructured":"Chen VC, et al. New use for old drugs: the protective effect of atypical antipsychotics on hepatocellular carcinoma. Int J Cancer. 2019;144:2428\u201339. https:\/\/doi.org\/10.1002\/ijc.31980.","journal-title":"Int J Cancer"},{"key":"2067_CR176","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fphar.2019.01517","volume":"10","author":"U Kim","year":"2019","unstructured":"Kim U, et al. Pimozide inhibits the human prostate cancer cells through the generation of reactive oxygen species. Front Pharmacol. 2019;10:1517. https:\/\/doi.org\/10.3389\/fphar.2019.01517.","journal-title":"Front Pharmacol"},{"key":"2067_CR177","doi-asserted-by":"publisher","first-page":"34889","DOI":"10.18632\/oncotarget.26175","volume":"9","author":"H el Dakir","year":"2018","unstructured":"el Dakir H, et al. The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget. 2018;9:34889\u2013910. https:\/\/doi.org\/10.18632\/oncotarget.26175.","journal-title":"Oncotarget"},{"key":"2067_CR178","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3892\/or.2019.7229","volume":"42","author":"JJ Chen","year":"2019","unstructured":"Chen JJ, Zhang LN, Cai N, Zhang Z, Ji K. Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer. Oncol Rep. 2019;42:1101\u20139. https:\/\/doi.org\/10.3892\/or.2019.7229.","journal-title":"Oncol Rep"},{"key":"2067_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092141","author":"A Ranjan","year":"2020","unstructured":"Ranjan A, Kaushik I, Srivastava SK. Pimozide suppresses the growth of brain tumors by targeting STAT3-mediated autophagy. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9092141.","journal-title":"Cells"},{"key":"2067_CR180","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1158\/0008-5472.Can-04-3011","volume":"65","author":"G Bug","year":"2005","unstructured":"Bug G, et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Can Res. 2005;65:2537\u201341. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-3011.","journal-title":"Can Res"},{"key":"2067_CR181","doi-asserted-by":"publisher","first-page":"21424","DOI":"10.1074\/jbc.M116.751503","volume":"291","author":"N Kawashima","year":"2016","unstructured":"Kawashima N, Nishimiya Y, Takahata S, Nakayama KI. Induction of glycosphingolipid GM3 expression by valproic acid suppresses cancer cell growth. J Biol Chem. 2016;291:21424\u201333. https:\/\/doi.org\/10.1074\/jbc.M116.751503.","journal-title":"J Biol Chem"},{"key":"2067_CR182","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3892\/or.2013.2747","volume":"30","author":"BR Han","year":"2013","unstructured":"Han BR, You BR, Park WH. Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis. Oncol Rep. 2013;30:2999\u20133005. https:\/\/doi.org\/10.3892\/or.2013.2747.","journal-title":"Oncol Rep"},{"key":"2067_CR183","doi-asserted-by":"publisher","first-page":"6190","DOI":"10.3892\/mmr.2017.7394","volume":"16","author":"S Mao","year":"2017","unstructured":"Mao S, et al. Valproic acid inhibits epithelial-mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression. Mol Med Rep. 2017;16:6190\u20139. https:\/\/doi.org\/10.3892\/mmr.2017.7394.","journal-title":"Mol Med Rep"},{"key":"2067_CR184","doi-asserted-by":"publisher","first-page":"95","DOI":"10.31768\/2312-8852.2018.40(2):95-100","volume":"40","author":"M Sanaei","year":"2018","unstructured":"Sanaei M, Kavoosi F, Mansoori O. Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro. Exp Oncol. 2018;40:95\u2013100.","journal-title":"Exp Oncol"},{"key":"2067_CR185","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622001","volume":"12","author":"R Sulsenti","year":"2021","unstructured":"Sulsenti R, et al. Repurposing of the antiepileptic drug levetiracetam to restrain neuroendocrine prostate cancer and inhibit mast cell support to adenocarcinoma. Front Immunol. 2021;12: 622001. https:\/\/doi.org\/10.3389\/fimmu.2021.622001.","journal-title":"Front Immunol"},{"key":"2067_CR186","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1734-1140(12)70742-9","volume":"64","author":"P Kwieci\u0144ska","year":"2012","unstructured":"Kwieci\u0144ska P, Taub\u00f8ll E, Gregoraszczuk EL. Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line. Pharmacol Rep. 2012;64:157\u201365. https:\/\/doi.org\/10.1016\/s1734-1140(12)70742-9.","journal-title":"Pharmacol Rep"},{"key":"2067_CR187","doi-asserted-by":"publisher","first-page":"9431","DOI":"10.1007\/s11033-023-08890-8","volume":"50","author":"A Sabokrouh","year":"2023","unstructured":"Sabokrouh A, Sadeghi Motlagh B, Atabi F. Study of anticancer effects of platinum levetiracetam and levetiracetam via cancer biomarkers genes expression on HepG2 cell line. Mol Biol Rep. 2023;50:9431\u20139. https:\/\/doi.org\/10.1007\/s11033-023-08890-8.","journal-title":"Mol Biol Rep"},{"key":"2067_CR188","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13046-017-0546-9","volume":"36","author":"A Rizzo","year":"2017","unstructured":"Rizzo A, et al. In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells. J Exp Clin Cancer Res. 2017;36:76. https:\/\/doi.org\/10.1186\/s13046-017-0546-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"2067_CR189","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11060-016-2056-6","volume":"127","author":"CY Lee","year":"2016","unstructured":"Lee CY, et al. The effects of antiepileptic drugs on the growth of glioblastoma cell lines. J Neurooncol. 2016;127:445\u201353. https:\/\/doi.org\/10.1007\/s11060-016-2056-6.","journal-title":"J Neurooncol"},{"key":"2067_CR190","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1541-7786.Mcr-17-0662","volume":"16","author":"M Pellegrino","year":"2018","unstructured":"Pellegrino M, et al. FoxO3a mediates the inhibitory effects of the antiepileptic drug lamotrigine on breast cancer growth. Mol Cancer Res. 2018;16:923\u201334. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-17-0662.","journal-title":"Mol Cancer Res"},{"key":"2067_CR191","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mol.107.039867","volume":"73","author":"AC Errington","year":"2008","unstructured":"Errington AC, St\u00f6hr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008;73:157\u201369. https:\/\/doi.org\/10.1124\/mol.107.039867.","journal-title":"Mol Pharmacol"},{"key":"2067_CR192","doi-asserted-by":"publisher","first-page":"115459","DOI":"10.1016\/j.ejmech.2023.115459","volume":"256","author":"H-J Tseng","year":"2023","unstructured":"Tseng H-J, et al. Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma. Europ J Med Chem. 2023;256:115459.","journal-title":"Europ J Med Chem"},{"key":"2067_CR193","doi-asserted-by":"publisher","first-page":"2204006","DOI":"10.1002\/advs.202204006","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu D, et al. Tryptophan metabolism acts as a new anti-ferroptotic pathway to mediate tumor growth. Adv Sci. 2023;10:2204006.","journal-title":"Adv Sci"},{"key":"2067_CR194","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pbb.2015.04.011","volume":"134","author":"SR Bang","year":"2015","unstructured":"Bang SR, et al. Lacosamide reduces HDAC levels in the brain and improves memory: Potential for treatment of Alzheimer\u2019s disease. Pharmacol Biochem Behav. 2015;134:65\u20139. https:\/\/doi.org\/10.1016\/j.pbb.2015.04.011.","journal-title":"Pharmacol Biochem Behav"},{"key":"2067_CR195","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1007\/s12035-017-0653-9","volume":"55","author":"A Moutal","year":"2018","unstructured":"Moutal A, et al. CRMP2 phosphorylation drives glioblastoma cell proliferation. Mol Neurobiol. 2018;55:4403\u201316. https:\/\/doi.org\/10.1007\/s12035-017-0653-9.","journal-title":"Mol Neurobiol"},{"key":"2067_CR196","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","volume":"149","author":"E Sachlos","year":"2012","unstructured":"Sachlos E, et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell. 2012;149:1284\u201397. https:\/\/doi.org\/10.1016\/j.cell.2012.03.049.","journal-title":"Cell"},{"key":"2067_CR197","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20:6969\u201378. https:\/\/doi.org\/10.1093\/emboj\/20.24.6969.","journal-title":"EMBO J"},{"key":"2067_CR198","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2174\/0118715206304918240509111700","volume":"24","author":"S Fayyaz","year":"2024","unstructured":"Fayyaz S, Atia Tul W, Irshad R, Siddiqui RA, Choudhary MI. Antidepressant sertraline hydrochloride inhibits the growth of HER2 AU565 breast cancer cell line through induction of apoptosis and cell cycle arrest. Anti-Cancer Agents Med Chem. 2024;24:1038\u201346. https:\/\/doi.org\/10.2174\/0118715206304918240509111700.","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"2067_CR199","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98921","author":"X Jiang","year":"2018","unstructured":"Jiang X, et al. Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy. JCI insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.98921.","journal-title":"JCI insight"},{"key":"2067_CR200","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00213-011-2190-y","volume":"216","author":"I Allaman","year":"2011","unstructured":"Allaman I, Fiumelli H, Magistretti PJ, Martin JL. Fluoxetine regulates the expression of neurotrophic\/growth factors and glucose metabolism in astrocytes. Psychopharmacology. 2011;216:75\u201384. https:\/\/doi.org\/10.1007\/s00213-011-2190-y.","journal-title":"Psychopharmacology"},{"key":"2067_CR201","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fphar.2015.00152","volume":"6","author":"S Roger","year":"2015","unstructured":"Roger S, Gillet L, Le Guennec JY, Besson P. Voltage-gated sodium channels and cancer: is excitability their primary role? Front Pharmacol. 2015;6:152. https:\/\/doi.org\/10.3389\/fphar.2015.00152.","journal-title":"Front Pharmacol"},{"key":"2067_CR202","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12:939\u201344. https:\/\/doi.org\/10.1038\/nm1447.","journal-title":"Nat Med"},{"key":"2067_CR203","doi-asserted-by":"crossref","unstructured":"Haghighat Lari MM, Banafshe HR, Seyed Hosseini E, Haddad Kashani HJI The effect of risperidone on behavioral reactions and gene expression of pro-and anti-inflammatory cytokines in neuropathic pain model induced by chronic constriction injury of the sciatic nerve in rat. 31, 2641-2652 (2023)","DOI":"10.1007\/s10787-023-01293-y"},{"key":"2067_CR204","first-page":"15288","volume":"24","author":"Y Son","year":"2023","unstructured":"Son Y, et al. Side-chain immune oxysterols induce neuroinflammation by activating microglia. Front Immunol. 2023;24:15288.","journal-title":"Front Immunol"},{"key":"2067_CR205","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.682612","volume":"12","author":"CR Falc\u00f3n","year":"2021","unstructured":"Falc\u00f3n CR, et al. Diazepam impairs innate and adaptive immune responses and ameliorates experimental autoimmune encephalomyelitis. Front Immunol. 2021;12: 682612.","journal-title":"Front Immunol"},{"key":"2067_CR206","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1080\/15548627.2019.1662585","volume":"15","author":"JM Bravo-San Pedro","year":"2019","unstructured":"Bravo-San Pedro JM, et al. Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI\/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor. Autophagy. 2019;15:2036\u20138.","journal-title":"Autophagy"},{"key":"2067_CR207","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2009.09.011","volume":"314","author":"N Fortunati","year":"2010","unstructured":"Fortunati N, et al. Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells. Mol Cell Endocrinol. 2010;314:17\u201322. https:\/\/doi.org\/10.1016\/j.mce.2009.09.011.","journal-title":"Mol Cell Endocrinol"},{"key":"2067_CR208","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.32604\/biocell.2024.054879","volume":"48","author":"JB Nair","year":"2024","unstructured":"Nair JB, Joseph AM, Joseph MM. Impact of nanoparticles on immune cells and their potential applications in cancer immunotherapy. Biocell. 2024;48:1579\u2013602.","journal-title":"Biocell"},{"key":"2067_CR209","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/1570159X14666160115130414","volume":"14","author":"M Schmidt","year":"2016","unstructured":"Schmidt M, Kirkby C, Lichtblau K. Inflammation and immune regulation as potential drug targets in antidepressant treatment. Curr Neuropharmacol. 2016;14:674\u201387.","journal-title":"Curr Neuropharmacol"},{"key":"2067_CR210","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CBJN. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234\u201356.","journal-title":"Neuron"},{"key":"2067_CR211","doi-asserted-by":"publisher","DOI":"10.2174\/01187614292595622309025055749","volume":"17","author":"L Liang","year":"2024","unstructured":"Liang L, et al. Maprotiline prompts an antitumour effect by inhibiting PD-L1 expression in mice with melanoma. Curr Mol Pharmacol. 2024;17: e18761429259562. https:\/\/doi.org\/10.2174\/01187614292595622309025055749.","journal-title":"Curr Mol Pharmacol"},{"key":"2067_CR212","first-page":"939","volume":"36","author":"HK Al-Hakeim","year":"2021","unstructured":"Al-Hakeim HK, Mousa RF, Al-Dujaili AH, Maes MJM. In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy. Schizophrenia Res. 2021;36:939\u201355.","journal-title":"Schizophrenia Res"},{"key":"2067_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","volume":"230","author":"D Enache","year":"2021","unstructured":"Enache D, et al. Peripheral immune markers and antipsychotic non-response in psychosis. Schizophrenia Res. 2021;230:1\u20138.","journal-title":"Schizophrenia Res"},{"key":"2067_CR214","doi-asserted-by":"publisher","first-page":"248","DOI":"10.20892\/j.issn.2095-3941.2023.0009","volume":"20","author":"W Yi","year":"2023","unstructured":"Yi W, Yan D, Wang D, Li Y. Smart drug delivery systems to overcome drug resistance in cancer immunotherapy. Cancer Biol Med. 2023;20:248\u201367. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0009.","journal-title":"Cancer Biol Med"},{"key":"2067_CR215","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/mp.2010.52","volume":"16","author":"RC Shelton","year":"2011","unstructured":"Shelton RC, et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry. 2011;16:751\u201362. https:\/\/doi.org\/10.1038\/mp.2010.52.","journal-title":"Mol Psychiatry"},{"key":"2067_CR216","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1158\/1078-0432.Ccr-15-2584","volume":"22","author":"H Zheng","year":"2016","unstructured":"Zheng H, et al. HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma. Clin Cancer Res. 2016;22:4119\u201332. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2584.","journal-title":"Clin Cancer Res"},{"issue":"351\u2013353","key":"2067_CR217","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3949\/ccjm.73.4.351","volume":"73","author":"EA Khawam","year":"2006","unstructured":"Khawam EA, Laurencic G, Malone DA Jr. Side effects of antidepressants: an overview. Clevel Clin J Med. 2006;73(351\u2013353):356\u201361. https:\/\/doi.org\/10.3949\/ccjm.73.4.351.","journal-title":"Clevel Clin J Med"},{"key":"2067_CR218","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.2174\/1570159x19666210826125341","volume":"19","author":"E Aky\u00fcz","year":"2021","unstructured":"Aky\u00fcz E, K\u00f6kl\u00fc B, Ozenen C, Arulsamy A, Shaikh MF. Elucidating the potential side effects of current anti-seizure drugs for epilepsy. Curr Neuropharmacol. 2021;19:1865\u201383. https:\/\/doi.org\/10.2174\/1570159x19666210826125341.","journal-title":"Curr Neuropharmacol"},{"key":"2067_CR219","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2174\/1570159x15666170630163616","volume":"16","author":"S Siafis","year":"2018","unstructured":"Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic drugs: from receptor-binding profiles to metabolic side effects. Curr Neuropharmacol. 2018;16:1210\u201323. https:\/\/doi.org\/10.2174\/1570159x15666170630163616.","journal-title":"Curr Neuropharmacol"},{"key":"2067_CR220","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/s1474-4422(03)00435-6","volume":"2","author":"CJ Vecht","year":"2003","unstructured":"Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptic and chemotherapeutic drugs. The Lancet Neurology. 2003;2:404\u20139. https:\/\/doi.org\/10.1016\/s1474-4422(03)00435-6.","journal-title":"The Lancet Neurology"},{"key":"2067_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109026","volume":"35","author":"M Norkin","year":"2021","unstructured":"Norkin M, Ord\u00f3\u00f1ez-Mor\u00e1n P, Huelsken J. High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer. Cell Rep. 2021;35: 109026. https:\/\/doi.org\/10.1016\/j.celrep.2021.109026.","journal-title":"Cell Rep"},{"key":"2067_CR222","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd5524","author":"CG Begley","year":"2021","unstructured":"Begley CG, et al. Drug repurposing: misconceptions, challenges, and opportunities for academic researchers. Sci Trans Med. 2021. https:\/\/doi.org\/10.1126\/scitranslmed.abd5524.","journal-title":"Sci Trans Med"},{"key":"2067_CR223","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","volume":"20","author":"EE Patton","year":"2021","unstructured":"Patton EE, Zon LI, Langenau DM. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. Nat Rev Drug Discovery. 2021;20:611\u201328. https:\/\/doi.org\/10.1038\/s41573-021-00210-8.","journal-title":"Nat Rev Drug Discovery"},{"key":"2067_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115425","volume":"28","author":"CA Lipinski","year":"2020","unstructured":"Lipinski CA, Reaume AG. High throughput in vivo phenotypic screening for drug repurposing: discovery of MLR-1023 a novel insulin sensitizer and novel Lyn kinase activator with clinical proof of concept. Bioorg Med Chem. 2020;28: 115425. https:\/\/doi.org\/10.1016\/j.bmc.2020.115425.","journal-title":"Bioorg Med Chem"},{"key":"2067_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115809","volume":"217","author":"A Oikonomou","year":"2023","unstructured":"Oikonomou A, et al. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia. Biochem Pharmacol. 2023;217: 115809. https:\/\/doi.org\/10.1016\/j.bcp.2023.115809.","journal-title":"Biochem Pharmacol"},{"key":"2067_CR226","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41467-021-21330-0","volume":"12","author":"S Rodriguez","year":"2021","unstructured":"Rodriguez S, et al. Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s disease. Nat Commun. 2021;12:1033. https:\/\/doi.org\/10.1038\/s41467-021-21330-0.","journal-title":"Nat Commun"},{"key":"2067_CR227","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.drudis.2022.02.004","volume":"27","author":"S Kumar","year":"2022","unstructured":"Kumar S, et al. Drug repurposing against SARS-CoV-2 using computational approaches. Drug Discovery Today. 2022;27:2015\u201327. https:\/\/doi.org\/10.1016\/j.drudis.2022.02.004.","journal-title":"Drug Discovery Today"},{"key":"2067_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106671","volume":"155","author":"H He","year":"2023","unstructured":"He H, et al. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications. Comput Biol Med. 2023;155: 106671. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106671.","journal-title":"Comput Biol Med"},{"key":"2067_CR229","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semcancer.2019.12.011","volume":"68","author":"NT Issa","year":"2021","unstructured":"Issa NT, Stathias V, Sch\u00fcrer S, Dakshanamurthy S. Machine and deep learning approaches for cancer drug repurposing. Semin Cancer Biol. 2021;68:132\u201342. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.011.","journal-title":"Semin Cancer Biol"},{"key":"2067_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105992","volume":"150","author":"S Doshi","year":"2022","unstructured":"Doshi S, Chepuri SP. A computational approach to drug repurposing using graph neural networks. Comput Biol Med. 2022;150: 105992. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105992.","journal-title":"Comput Biol Med"},{"key":"2067_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106960","volume":"199","author":"Z Gao","year":"2024","unstructured":"Gao Z, Ding P, Xu R. IUPHAR review - data-driven computational drug repurposing approaches for opioid use disorder. Pharmacol Res. 2024;199: 106960. https:\/\/doi.org\/10.1016\/j.phrs.2023.106960.","journal-title":"Pharmacol Res"},{"key":"2067_CR232","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.665832","volume":"11","author":"Y Cui","year":"2021","unstructured":"Cui Y, et al. Chlorpromazine sensitizes progestin-resistant endometrial cancer cells to MPA by upregulating PRB. Front Oncol. 2021;11: 665832. https:\/\/doi.org\/10.3389\/fonc.2021.665832.","journal-title":"Front Oncol"},{"key":"2067_CR233","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c00638","author":"X Ling","year":"2024","unstructured":"Ling X, et al. Discovery of Novel Azaphenothiazine derivatives to suppress endometrial cancer by targeting GRP75 to impair its interaction with ip3r and mitochondrial Ca(2+) homeostasis. J Med Chem. 2024. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00638.","journal-title":"J Med Chem"},{"key":"2067_CR234","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jphs.2018.06.014","volume":"137","author":"Z Xie","year":"2018","unstructured":"Xie Z, Ago Y, Okada N, Tachibana M. Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells. J Pharmacol Sci. 2018;137:359\u201365. https:\/\/doi.org\/10.1016\/j.jphs.2018.06.014.","journal-title":"J Pharmacol Sci"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02067-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02067-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02067-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T02:22:22Z","timestamp":1743214942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02067-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02067-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}